Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...

aDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University, Berlin, Germany, bDepartment of Rheumatology and Physical Medicine, University Hospital, Zurich, ...

1 Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands 2 Department of Rheumatology, University Medical Centre Nijmegen, The Netherlands 3 Department of Rheumatology, Leiden ...

1 Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria 2 2nd Department of Medicine, Hietzing Hospital Vienna, Vienna, Austria 3 Department of Rheumatology ...

Objective To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS). Methods This phase III, randomised, double-blind, placebo-controlled study enrolled ...

The goal of the Bone and Joint Decade is to improve the health related quality of life for people with musculoskeletal disorders throughout the world. Musculoskeletal disorders are the most common ...

Study of the genetics of rheumatoid arthritis (RA) began about four decades ago with the discovery of HLA-DRB1. Since the beginning of this century, a number of non-HLA risk loci have been identified ...

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...

Objectives The goals of these studies were to elucidate the inter-relationships of specific anti-nuclear antibody (ANA), complement, and the interferon gene signature (IGS) in the pathogenesis of ...

Objectives The prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases who are frequently treated with disease modifying therapies remains poorly understood. This ...

Background Methotrexate is the anchor drug used most widely as monotherapy or combination therapy with other DMARDS & biologics in treatment of RA. It is widely perceived by clinicians to have ...

Department of Medicine and Resnick Gerontology Center, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA Dr D Hamerman, Department of Medicine and Resnick Gerontology ...